158 related articles for article (PubMed ID: 35834040)
21. Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.
Wang X; Sun Q; Cui C; Li J; Wang Y
Drug Des Devel Ther; 2018; 12():2841-2855. PubMed ID: 30233146
[TBL] [Abstract][Full Text] [Related]
22. Anti-angiogenesis and anticancer effects of a plasmid expressing both ENDO-VEGI151 and small interfering RNA against survivin.
Li Z; Yang S; Chang T; Cao X; Shi L; Fang G
Int J Mol Med; 2012 Mar; 29(3):485-90. PubMed ID: 22109572
[TBL] [Abstract][Full Text] [Related]
23. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
24. [Effects of survivin gene silencing by small interfering RNA on apoptosis of oral squamous cell carcinoma].
Liu S; Liang X; Bao C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Aug; 31(4):345-7, 352. PubMed ID: 23991568
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous Delivery of Electrostatically Complexed Multiple Gene-Targeting siRNAs and an Anticancer Drug for Synergistically Enhanced Treatment of Prostate Cancer.
Choi E; Yoo W; Park JH; Kim S
Mol Pharm; 2018 Sep; 15(9):3777-3785. PubMed ID: 30028622
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene.
Cai M; Wang G; Tao K; Cai C
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):45-9. PubMed ID: 19224161
[TBL] [Abstract][Full Text] [Related]
27. [Suppression of survivin gene in leukemia cells by small interfering RNA].
Wang TY; Feng SQ; Zhang ZX; Shi XD; Liu R; Liu ZQ
Zhonghua Er Ke Za Zhi; 2010 Nov; 48(11):843-7. PubMed ID: 21215029
[TBL] [Abstract][Full Text] [Related]
28. [siRNA targeted against survivin induces apoptosis of pancreatic cancer cells].
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):169-73. PubMed ID: 16503521
[TBL] [Abstract][Full Text] [Related]
29. Induction function of siRNA-mediated survivin gene silencing on nasopharyngeal carcinoma cell apoptosis.
Fu SM; Tu ZH; Deng LQ; Cai JH; Liang Z; Lin ZQ; Wang YT
Genet Mol Res; 2015 Mar; 14(1):2537-45. PubMed ID: 25867400
[TBL] [Abstract][Full Text] [Related]
30. Designing Nanomedicines for Breast Cancer Therapy.
Abbasi Dezfouli S; Rajendran AP; Claerhout J; Uludag H
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892241
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
Mattheolabakis G; Ling D; Ahmad G; Amiji M
Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
35. [Effects of siRNA targeted to survivin in suppressing proliferation and inducing apoptosis in breast cancer MCF-7 cells].
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):326-30. PubMed ID: 17044992
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells.
Doan CC; Le LT; Hoang SN; Do SM; Le DV
Biol Res; 2014 Dec; 47(1):70. PubMed ID: 25723613
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of a novel survivin siRNA.
Li Y; Li Y; Lee RJ; Wang X; Du L; Zhao L; Liu Y; Teng L
Pak J Pharm Sci; 2015 Sep; 28(5 Suppl):1887-90. PubMed ID: 26525031
[TBL] [Abstract][Full Text] [Related]
38. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H
J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345
[TBL] [Abstract][Full Text] [Related]
39. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
40. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F
J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
